Restrictive cardiomyopathy
Restrictive cardiomyopathy | |
---|---|
Other names | Obliterative cardiomyopathy, infiltrative cardiomyopathy, constrictive cardiomyopathy Congo red stain. |
Specialty | Cardiology |
Restrictive cardiomyopathy (RCM) is a form of cardiomyopathy in which the walls of the heart are rigid (but not thickened).[2][3] Thus the heart is restricted from stretching and filling with blood properly. It is the least common of the three original subtypes of cardiomyopathy: hypertrophic, dilated, and restrictive.[1]
It should not be confused with constrictive pericarditis, a disease which presents similarly but is very different in treatment and prognosis.[1]
Signs and symptoms
Untreated hearts with RCM often develop the following characteristics:[4]
- M or W configuration in an invasive hemodynamic pressure tracing of the RA
- Square root sign of part of the invasive hemodynamic pressure tracing Of The LV
- Biatrial enlargement
- Thickened LV walls (with normal chamber size)
- Thickened RV free wall (with normal chamber size)
- Elevated right atrial pressure (>12mmHg),
- Moderate pulmonary hypertension,
- Normal systolic function,
- Poor diastolic function, typically Grade III - IV Diastolic heart failure.
Those affected by RCM will experience decreased exercise tolerance, fatigue, jugular venous distention, peripheral edema, and ascites.[3] Arrhythmias and conduction blocks are common.
Causes
RCM can be caused by genetic or non-genetic factors.[5][6][7] Thus it is possible to divide the causes into primary and secondary.[8] The common modern organization is into Infiltrative, storage diseases, non-infiltrative, and endomyocardial etiologies:[9]
- Genetic
- Infiltrative
- Storage diseases
- Fabry disease
- Gaucher disease
- Hereditary hemochromatosis
- Glycogen storage disease
- Mucopolysaccharidosis type I (Hurler syndrome)
- Mucopolysaccharidosis type II (Hunter syndrome)
- Niemann-Pick disease
- Non-infiltrative
- Idiopathic
- Diabetic cardiomyopathy
- Scleroderma
- Myofibrillar myopathies
- Pseudoxanthoma elasticum
- Sarcomeric protein disorders
- Werner's syndrome
- Endomyocardial
- Carcinoid heart disease
- Endomyocardial fibrosis
- Idiopathic
- Hypereosinophilic syndrome
- Chronic eosinophilic leukemia
- Drugs (serotonin, methysergide, ergotamine, mercurial agents, busulfan)
- Endocardial fibroelastosis
- Consequence of cancer or cancer therapy
- Metastatic cancer
- Drugs (anthracyclines)
- Radiation
The most common cause of restrictive cardiomyopathy is amyloidosis.[3]
Mechanism
Rhythmicity and contractility of the heart may be normal, but the stiff walls of the heart chambers (atria and ventricles) keep them from adequately filling, reducing preload and end-diastolic volume. Thus, blood flow is reduced, and blood volume that would normally enter the heart is backed up in the circulatory system. In time, restrictive cardiomyopathy patients develop diastolic dysfunction and eventually heart failure.[13]
Diagnosis
Diagnosis is typically made via echocardiography. Patients will demonstrate normal systolic function, diastolic dysfunction, and a restrictive filling pattern.
Treatment
Treatment of restrictive cardiomyopathy should focus on management of causative conditions (for example, using corticosteroids if the cause is sarcoidosis), and slowing the progression of cardiomyopathy.
Calcium channel blockers are generally contraindicated due to their negative inotropic effect, particularly in cardiomyopathy caused by amyloidosis.[17][18] Digoxin, calcium channel blocking drugs and beta-adrenergic blocking agents provide little benefit, except in the subgroup of restrictive cardiomyopathy with atrial fibrillation.[19] Vasodilators are also typically ineffective because systolic function is usually preserved in cases of RCM.[3]
Heart failure resulting from restrictive cardiomyopathy will usually eventually have to be treated by
Epidemiology
Endomyocardial fibrosis is generally limited to the tropics and sub-saharan Africa.[9] The highest incidence of death caused by cardiac sarcoidosis is found in Japan.[20]
References
- ^ PMID 11514495.
- ^ "restrictive cardiomyopathy" at Dorland's Medical Dictionary
- ^ )
- PMID 28912185.
- S2CID 35455240.
- S2CID 13942559.
- PMID 31718026.
- ISBN 978-0-8385-1473-3.
- ^ PMID 28912185.
- PMID 31718026.
- S2CID 13942559.
- S2CID 35455240.
- ^ "Restrictive Cardiomyopathy". The Lecturio Medical Concept Library. Retrieved 28 June 2021.
- ^ Nihoyannopoulos, P and D Dawson. 2009. Restrictive cardiomyopathies. European Journal of Echocardiography , Volume 10, Issue 8, Pages iii23–iii33, https://doi.org/10.1093/ejechocard/jep156
- ^ a b "Restrictive Cardiomyopathy Treatment & Management". 2014-12-18. Retrieved 2015-06-10.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ Muchtar, E, LA Blauwet and MA Gertz. 2017. Restrictive cardiomyopathy: genetics, Ppathogenesis, clinical manifestations, diagnosis, and therapy. Circulation Research. 121:819–837. https://doi.org/10.1161/CIRCRESAHA.117.310982
- PMID 8339658.
- PMID 4003314.
- S2CID 45162583.
- PMID 26885492.
External links
- Overview at Merck Manual